On this page · 4 sections→
Where the EU money came from
Funding by EU programme. Amounts are Psioxus Therapeutics's own share of each project, not the project's full budget.
- FP7 (2007 to 2013)€261k · 1 project
Projects
1 EU-funded project, newest first. Each links to the official record.
- ADVANCEPartner
ADenoViruses as novel clinical treatments
FP7 (2007 to 2013) · 2012–2016 · Project on CORDIS ↗
€261ktheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- Centre National de la Recherche Scientifique CNRSFrance · 1 shared project
- The Chancellor, Masters and Scholars of the University of OxfordUnited Kingdom · 1 shared project
- University of GlasgowUnited Kingdom · 1 shared project
- Ita-Suomen YliopistoFinland · 1 shared project
- Universitat ZurichSwitzerland · 1 shared project
- Umea UniversitetSweden · 1 shared project
- Fundacio Institut D'Investigacio Biomedica de BellvitgeSpain · 1 shared project
- Hun-Ren Agrartudomanyi KutatokozpontHungary · 1 shared project
- Batavia Biosciences BVNetherlands · 1 shared project
- Janssen Vaccines & Prevention BVNetherlands · 1 shared project
- Targovax OyFinland · 1 shared project
- Magyar Tudomanyos Akademia Allatorvos-Tudomanyi KutatointezeteHungary · 1 shared project
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗